Missouri Health Digest: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Missouri Health Digest.

Press releases published on May 4, 2026

May. 4, 2026

TinySuperheroes Launches May Discovery Mission with Support from SFC Group to Spark Curiosity and Social Awareness

Indeterminate EIN Presswire

14 hours ago

Pennant Announces First Quarter 2026 Earnings Release and Call

Indeterminate GlobeNewswire

15 hours ago

Janell Rae Releases Debut Book Satori: Awakening to Your Truest Self Through Energy Intelligence

Indeterminate GlobeNewswire

15 hours ago

Ballad Health invests $15 million to expand robotic-assisted surgery, earns national accreditation for quality and surgical excellence

Indeterminate GlobeNewswire

16 hours ago

Elite Pro Force Male Enhancement Gummies Claims Evaluated: The Ultra Peak Horse Gelatin Trick for Men

Indeterminate GlobeNewswire

16 hours ago

Nanobiotix Announces Protocol Amendment to Ongoing Global Phase 3 Head and Neck Cancer Study

Indeterminate GlobeNewswire

16 hours ago

NANOBIOTIX ANNONCE UN AMENDEMENT DU PROTOCOLE DE L’ÉTUDE MONDIALE DE PHASE 3 SUR LE CANCER DE LA TÊTE ET DU COU

Indeterminate GlobeNewswire

16 hours ago

JellyFit Claims Evaluated: The Truth About Jelly Lean Fit Weight Loss Drops' 8 Ingredients Stacked with Gelatin Trick Recipe Hack Exposed

Indeterminate GlobeNewswire

17 hours ago

Dentsply Sirona Expands U.S. Distribution Footprint Through Enhanced Agreement with Atlanta Dental Supply

Indeterminate GlobeNewswire

17 hours ago

New Publication Demonstrates TLX250-Px (Zircaix®) Potential in Diagnosing Kidney Cancers Beyond ccRCC

Indeterminate GlobeNewswire

17 hours ago

Tango Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

17 hours ago

Teva to Present at the BofA Securities Health Care Conference

Indeterminate GlobeNewswire

17 hours ago

Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

17 hours ago

Cellectis to Report First Quarter Financial Results on May 11, 2026

Indeterminate GlobeNewswire

17 hours ago

Cellectis publiera ses résultats financiers du premier trimestre le 11 mai 2026

Indeterminate GlobeNewswire

17 hours ago

Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

17 hours ago

CRISPR Therapeutics Provides Business Update and Reports First Quarter 2026 Financial Results

Indeterminate GlobeNewswire

17 hours ago

Jushi Holdings Inc. to Report First Quarter 2026 Financial Results on May 12, 2026

Indeterminate GlobeNewswire

17 hours ago

Opus Genetics Announces FDA Acceptance of OPGx-LCA5 into Rare Disease Evidence Principles (RDEP) Program

Indeterminate GlobeNewswire

17 hours ago

Eton Pharmaceuticals to Report First Quarter 2026 Financial Results on Thursday, May 14, 2026

Indeterminate GlobeNewswire